ингибиторы фосфодиэстеразы-5 в лечении простатита
 

ингибиторы фосфодиэстеразы-5 в лечении простатита/простатодинии или как доктора пересадили пациента с морфина на циалис:

We recently encountered a patient, effectively disabled by prostatodynia, unresponsive to standard treatment, who had been taking morphine to control the pain from 2001 to 2008. He was unable to tolerate NSAIDs. In 2008, he was prescribed initially 10 mg, then 20 mg daily, of the PDE5 inhibitor tadalafil, with immediate marked improvement of his symptoms. On cessation of the medication on four separate occasions, his symptoms returned; recommencement of treatment each time, with 5 mg tadalafil daily, has resulted in similar persisting improvement of his symptoms, and he has been able to discontinue treatment with morphine. As a direct consequence of the conversation with this individual, we have prescribed tadalafil 5 mg daily in several of our patients with prostatitis; so far with uniformly beneficial results.
---
Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia?
Kirby RS, Carson C 3rd, Dasgupta P.
BJU Int. 2014 May;113(5):694-5.
[Ссылки могут видеть только зарегистрированные пользователи. ]